GPP
EOLS icon

Great Point Partners’s Evolus EOLS Stock Holding History

Great Point Partners’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-720,118
Closed -$6.63M – 34
2025
Q2 		$6.63M Sell
720,118
-224,625
-24% -$2.3M 4.31% 8
2025
Q1 		$11.4M Buy
944,743
+49,219
+5% +$644K 6.02% 3
2024
Q4 		$9.89M Sell
895,524
-274,476
-23% -$3.86M 4.66% 9
2024
Q3 		$19M Sell
1,170,000
-1,281,772
-52% -$17.9M 5.58% 4
2024
Q2 		$26.6M Buy
2,451,772
+1,772
+0.1% +$21.8K 5.1% 8
2024
Q1 		$34.3M Buy
2,450,000
+450,000
+23% +$5.85M 5.35% 5
2023
Q4 		$21.1M Sell
2,000,000
-186,934
-9% -$1.67M 3.59% 11
2023
Q3 		$20M Sell
2,186,934
-247,114
-10% -$2.22M 3.64% 10
2023
Q2 		$17.7M Buy
2,434,048
+241,232
+11% +$2.08M 3.46% 14
2023
Q1 		$18.6M Buy
2,192,816
+2,002,487
+1,052% +$18.1M 3.64% 11
2022
Q4 		$1.43M Buy
+190,329
New +$1.47M 0.28% 39

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Great Point Partners's EOLS Position: Q3 2025 in Review

Great Point Partners sold out of Evolus (EOLS) in Q3 2025, closing a stake of 720,118 shares — an estimated $6.63M sold.

Great Point Partners first reported a position in EOLS in Q4 2022 and held it in 11 quarters. The position peaked at $34.3M in Q1 2024. 160 funds tracked by Wall St. Rank hold EOLS as of Q3 2025.

  • Great Point Partners reported no remaining Evolus position as of Q3 2025 after selling out during the quarter.
  • Great Point Partners sold 720,118 Evolus shares in Q3 2025, an estimated $6.63M.
  • Great Point Partners first reported a position in Evolus in Q4 2022 and held it in 11 quarters.
  • Great Point Partners's Evolus position peaked at $34.3M in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Evolus as of Q3 2025.

Based on Great Point Partners's 13F filing for Q3 2025, filed 14 Nov 2025.